Madan Jagasia, MBBS, MS, of the Vanderbilt University Medical Center discussed the next steps in treating acute graft versus host disease with ruxolitinib.
Madan Jagasia, MBBS, MS
Advertisement
Articles by Madan Jagasia, MBBS, MS
Advertisement
Latest Updated Articles
Madan Jagasia, MBBS, MS, on Ruxolitinib to Treat Steroid Refractory GvHDPublished: March 5th 2020 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Dato-DXd and the TROPION Trials Are Transforming Solid Tumor Research
2
Could Scorpion Venom Component Play a Role in Glioblastoma Management?
3
Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC
4
FDA Approves Abbreviated NDA for Dasatinib Tablets in Leukemia Indications
5
